Medicine Platform
搜索
Product Catagories
首页 > Pharmaceutical Materials > Ixazomib Citrate; CAS:1201902-80-8
Ixazomib Citrate; CAS:1201902-80-8
单价 面议对比
询价 暂无
发货
过期 长期有效
更新 2025-08-14 05:41
 
详细信息

Grade: Pharmaceutical Grade

Factory Location: No. 55, South Shunjiang Avenue, East Economic Development Zone, Dongpo District, Meishan City, Sichuan, 620036 ,China

Main Sales Markets: Asia

Sample Provided: no

Payment Terms: T/T

Ixazomib, a second-generation proteasome inhibitor, is used primarily in the treatment of multiple myeloma. This activity outlines the mechanism of action, indications, and contraindications for ixazomib as a valuable agent for treating multiple myeloma.